CAPTRUST Financial Advisors’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-150
Closed 3388
2020
Q2
$0 Buy
+150
New ﹤0.01% 2957
2019
Q4
Sell
-9
Closed 2049
2019
Q3
$0 Hold
9
﹤0.01% 2088
2019
Q2
$0 Buy
+9
New ﹤0.01% 2071

CAPTRUST Financial Advisors's IPCI Position: Q3 2020 in Review

CAPTRUST Financial Advisors sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2020, closing a stake of 150 shares.

CAPTRUST Financial Advisors first reported a position in IPCI in Q2 2019 and held it in 3 quarters. The position peaked at $0 in Q2 2020. 0 funds tracked by Wall St. Rank hold IPCI as of Q3 2020.

  • CAPTRUST Financial Advisors reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2020 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 150 Intellipharmaceuticals International Inc. shares in Q3 2020.
  • CAPTRUST Financial Advisors first reported a position in Intellipharmaceuticals International Inc. in Q2 2019 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's Intellipharmaceuticals International Inc. position peaked at $0 in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2020.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2020, filed 17 Nov 2020.